GENOSS Coronary Stent Clinical Trial
Recruiting
N/A
Interventional Study
Ischemic Heart Disease
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 19 and older
- Sex
- Any
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 850 (estimated)
- Sponsor
- Samsung Medical Center · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
This study aims to evaluate the efficacy and safety of abluminal biodegradable polymer ultrathin sirolimus-eluting stent (Genoss stent) as compared with a durable-polymer everolimus-eluting stent (Xience stent) in patients with coronary artery disease.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
① Subject must be at least 19 years of age
② Subject who is able to understand risks, benefits and treatment alternatives and sign informed consent voluntarily.
③ Patients with stable coronary artery disease or acute coronary syndrome and at least one lesion with greater than …
Contacts